Under-40s in Britain to be offered alternative to AstraZeneca vaccine -newspapers

Under-40s in Britain to be offered alternative to AstraZeneca vaccine -newspapers

People under the age of 40 in Britain will be offered an alternative to the Oxford/AstraZeneca (AZN.L) COVID-19 vaccine following concerns of rare blood clots, The Daily Telegraph and The Independent newspapers reported on Thursday. The Joint …
See Original Article

How an Oil Company Becomes a Renewables Company

At the same time, some of the majors increased their energy transition commitments: as my Bloomberg Intelligence colleagues Salih Yilmaz and Will
See Original Article

USPS Turns to AI at the Edge to Boost Package Processing

An edge artificial intelligence platform recently implemented by the U.S. Postal Service is helping federal insiders trace the many millions of packages it processes each week in a matter of hours instead of multiple days. Open-source software from Nvidia is …
See Original Article

Moderna Turns First Profit, Boosted by Its Covid-19 Vaccine

The vaccine brought Moderna revenue of $1.73 billion in the first quarter, reflecting three full months of its use in the U.S. and initial international sales, the company said Thursday. Moderna also boosted its full …
See Original Article

Study: SPACs surge shakes up first-quarter IPO market

Bukzin recommends accounting firms develop expertise in this area; Marcum has a separate group of 15 partners and between 60 and 70 staff
See Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.